|Unique CD14+ intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-γ axis|
N Kamada, T Hisamatsu, S Okamoto, H Chinen, T Kobayashi, T Sato, ...
The Journal of clinical investigation 118 (6), 2269-2280, 2008
|Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease|
H Takaishi, T Matsuki, A Nakazawa, T Takada, S Kado, T Asahara, ...
International Journal of Medical Microbiology 298 (5-6), 463-472, 2008
|Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease|
A Sakuraba, T Sato, N Kamada, M Kitazume, A Sugita, T Hibi
Gastroenterology 137 (5), 1736-1745, 2009
|Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients|
K Matsuoka, Y Iwao, T Mori, A Sakuraba, T Yajima, T Hisamatsu, ...
American Journal of Gastroenterology 102 (2), 331-337, 2007
|T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn’s disease|
K Matsuoka, N Inoue, T Sato, S Okamoto, T Hisamatsu, Y Kishi, ...
Gut 53 (9), 1303-1308, 2004
|Animal models of inflammatory bowel disease|
T Hibi, H Ogata, A Sakuraba
Journal of gastroenterology 37 (6), 409-417, 2002
|Osteopontin/Eta-1 upregulated in Crohn’s disease regulates the Th1 immune response|
T Sato, T Nakai, N Tamura, S Okamoto, K Matsuoka, A Sakuraba, ...
Gut 54 (9), 1254-1262, 2005
|Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or-dependent ulcerative colitis|
M Naganuma, S Funakoshi, A Sakuraba, H Takagi, N Inoue, H Ogata, ...
Inflammatory bowel diseases 10 (3), 251-257, 2004
|An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared …|
A Sakuraba, S Motoya, K Watanabe, M Nishishita, K Kanke, T Matsui, ...
American Journal of Gastroenterology 104 (12), 2990-2995, 2009
|Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet's disease|
M Naganuma, A Sakuraba, T Hisamatsu, H Ochiai, H Hasegawa, H Ogata, ...
Inflammatory bowel diseases 14 (9), 1259-1264, 2008
|Systematic review with meta‐analysis: the efficacy and safety of CT‐P13, a biosimilar of anti‐tumour necrosis factor‐α agent (infliximab), in inflammatory bowel diseases|
Y Komaki, A Yamada, F Komaki, D Micic, A Ido, A Sakuraba
Alimentary pharmacology & therapeutics 45 (8), 1043-1057, 2017
|Retrieval of serum infliximab level by shortening the maintenance infusion interval is correlated with clinical efficacy in Crohn's disease|
T Hibi, A Sakuraba, M Watanabe, S Motoya, H Ito, K Motegi, Y Kinouchi, ...
Inflammatory Bowel Diseases 18 (8), 1480-1487, 2012
|C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn’s disease|
T Hibi, A Sakuraba, M Watanabe, S Motoya, H Ito, N Sato, T Yoshinari, ...
Journal of gastroenterology 49 (2), 254-262, 2014
|Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review|
J Melek, A Sakuraba
Clinical Gastroenterology and Hepatology 12 (1), 32-44. e5, 2014
|Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease|
T Sato, T Kanai, M Watanabe, A Sakuraba, S Okamoto, T Nakai, ...
Gastroenterology 126 (3), 829-839, 2004
|Risk of postoperative complications among inflammatory bowel disease patients treated preoperatively with vedolizumab|
A Yamada, Y Komaki, N Patel, F Komaki, AS Aelvoet, AL Tran, J Pekow, ...
American Journal of Gastroenterology 112 (9), 1423-1429, 2017
|Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis|
K Meckel, YC Li, J Lim, M Kocherginsky, C Weber, A Almoghrabi, X Chen, ...
The American journal of clinical nutrition 104 (1), 113-120, 2016
|Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-α use in females with immune mediated diseases; a systematic review and meta-analysis|
F Komaki, Y Komaki, D Micic, A Ido, A Sakuraba
Journal of autoimmunity 76, 38-52, 2017
|Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis|
A Yamada, Y Komaki, F Komaki, D Micic, S Zullow, A Sakuraba
The Lancet Oncology 19 (6), 758-767, 2018
|A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis|
A Sakuraba, T Sato, M Naganuma, Y Morohoshi, K Matsuoka, N Inoue, ...
Journal of gastroenterology 43 (1), 51-56, 2008